Eric D. Shaff, CFO and EVP at Seres Therapeutics, Inc. (MCRB), sold 7,663 shares at $26.50 ($202K) on 2016-03-31, disclosed to the SEC on 2016-04-04.
Scheduled sale ($202k) by CFO and EVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.13 | 1,095 | $28K | 13.7% |
| 2 | $26.50 | 6,568 | $174K | 86.3% |
| Total | $26.30 avg | 7,663 | $202K | 100% |
| Filing → |
| MCRB | SELL | 2026-02-18 | $2K | — | Filing → |
| MCRB | SELL | 2025-11-18 | $4K | — | Filing → |
| MCRB | SELL | 2025-08-19 | $4K | — | Filing → |